Literature DB >> 14616863

Early-life exposure to antibacterials and the subsequent development of hayfever in childhood in the UK: case-control studies using the General Practice Research Database and the Doctors' Independent Network.

S A Bremner1, I M Carey, S DeWilde, N Richards, W C Maier, S R Hilton, D P Strachan, D G Cook.   

Abstract

BACKGROUND: Theoretically, antibacterial agents in early life might influence allergic sensitization in two ways: (i) as an indicator of infectious illness, they might be expected to protect against allergy; (ii) alternatively they might increase the risk through effects on the commensal bowel flora. Epidemiological evidence linking the prescription of antibacterial agents in early life to the subsequent development of hayfever is conflicting.
OBJECTIVE: To establish definitively whether an association exists between early-life antibacterial exposure and childhood hayfever diagnosis.
METHODS: Nested case-control studies were based on birth cohorts of children identified within two large UK general practice databases of electronic patient records. One hundred and sixteen thousand and four hundred and ninety-three children from 605 general practices were identified as being continuously registered from birth to at least age 5 years. Seven thousand and ninety-eight cases were diagnosed with hayfever after the age of 2 years. One control per case was matched for practice, birth month, sex and still being registered on case diagnosis date. Odds ratios were derived from conditional logistic regressions within each database followed by pooling using a fixed-effect model.
RESULTS: The pooled odds ratio for hayfever was 1.11, 95% CI (1.03-1.20) if exposed to antibacterials in the first year of life, 1.35 (1.25-1.46) in year 2 and 1.47 (1.37-1.59) in year 3. Adjusting for consultation frequency reduced these odds ratios to 0.92, 1.05 and 1.10, respectively. There was no evidence that broader spectrum antibacterials, exposure in any specific month of year 1 or in the grass pollen season influenced the risk of hayfever.
CONCLUSION: These data exclude any important effect of antibacterial exposure in infancy on subsequent hayfever risk. Associations reported in earlier studies have likely been exaggerated through publication bias and by lack of control for the tendency of some families to consult frequently for a range of conditions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14616863     DOI: 10.1046/j.1365-2222.2003.01794.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  8 in total

1.  Timing of routine immunisations and subsequent hay fever risk.

Authors:  S A Bremner; I M Carey; S DeWilde; N Richards; W C Maier; S R Hilton; D P Strachan; D G Cook
Journal:  Arch Dis Child       Date:  2005-06       Impact factor: 3.791

2.  Recorded infections and antibiotics in early life: associations with allergy in UK children and their parents.

Authors:  Jessica M Harris; Pamela Mills; Carol White; Susan Moffat; Anthony J Newman Taylor; Paul Cullinan
Journal:  Thorax       Date:  2007-02-08       Impact factor: 9.139

3.  Spurious trends in coronary heart disease incidence: unintended consequences of the new GP contract?

Authors:  Iain M Carey; Stephen Dewilde; Tess Harris; Peter H Whincup; Derek G Cook
Journal:  Br J Gen Pract       Date:  2007-06       Impact factor: 5.386

4.  Can analyses of electronic patient records be independently and externally validated? Study 2--the effect of β-adrenoceptor blocker therapy on cancer survival: a retrospective cohort study.

Authors:  David A Springate; Darren M Ashcroft; Evangelos Kontopantelis; Tim Doran; Ronan Ryan; David Reeves
Journal:  BMJ Open       Date:  2015-04-13       Impact factor: 2.692

5.  Can analyses of electronic patient records be independently and externally validated? The effect of statins on the mortality of patients with ischaemic heart disease: a cohort study with nested case-control analysis.

Authors:  David Reeves; David A Springate; Darren M Ashcroft; Ronan Ryan; Tim Doran; Richard Morris; Ivan Olier; Evangelos Kontopantelis
Journal:  BMJ Open       Date:  2014-04-23       Impact factor: 2.692

6.  Implications of the problem orientated medical record (POMR) for research using electronic GP databases: a comparison of the Doctors Independent Network Database (DIN) and the General Practice Research Database (GPRD).

Authors:  Iain M Carey; Derek G Cook; Stephen De Wilde; Stephen A Bremner; Nicky Richards; Steve Caine; David P Strachan; Sean R Hilton
Journal:  BMC Fam Pract       Date:  2003-09-30       Impact factor: 2.497

7.  Knowledge discovery of drug data on the example of adverse reaction prediction.

Authors:  Pinar Yildirim; Ljiljana Majnarić; Ozgur Ekmekci; Andreas Holzinger
Journal:  BMC Bioinformatics       Date:  2014-05-16       Impact factor: 3.169

8.  Approaches for combining primary care electronic health record data from multiple sources: a systematic review of observational studies.

Authors:  Daniel Dedman; Melissa Cabecinha; Rachael Williams; Stephen J W Evans; Krishnan Bhaskaran; Ian J Douglas
Journal:  BMJ Open       Date:  2020-10-14       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.